Article
TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.
Genes, chromosomes & cancer - 1 Sept 1995
Børresen A L, Andersen T I, Eyfjörd J E, Cornelis R S, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S
Abstract excerpt
Acquired mutations in TP53 as well as immunohistochemically detectable protein expression have been implicated as prognostic factors for breast cancer. We have evaluated the relationship between mutations detected in 119 breast tumours and various clinicohistopathological indices, stratifying the mutations according to the functional domains as defined by the recent elucidation of the crystal structure of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
